[Dipper and non-dipper].
Fukutomi
Motoki
M
Yamaguchi Grand Medical Center.
Matsui
Yoshio
Y
Shimada
Kazuyuki
K
D047228:Angiotensin II Type 1 Receptor Blockers / Q000008:administration & dosage; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage; D000959:Antihypertensive Agents / Q000008:administration & dosage; D001794:Blood Pressure; D018660:Blood Pressure Monitoring, Ambulatory; D002121:Calcium Channel Blockers / Q000008:administration & dosage; D002561:Cerebrovascular Disorders / Q000150:complications / Q000503:physiopathology; D002940:Circadian Rhythm; D006801:Humans; D006973:Hypertension / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D007674:Kidney Diseases / Q000150:complications / Q000503:physiopathology; D011379:Prognosis; D012084:Renin-Angiotensin System / Q000502:physiology; D012891:Sleep Apnea Syndromes / Q000150:complications / Q000503:physiopathology; D049993:Sodium Chloride Symporter Inhibitors / Q000008:administration & dosage; D013564:Sympathetic Nervous System / Q000503:physiopathology
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D049993:Sodium Chloride Symporter Inhibitors